35 results
8-K
EX-10.1
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
by will or intestate succession upon the death of the undersigned; (d) transfer of shares of Common Stock or any securities convertible into or exercisable
424B5
gyxobu
18 Mar 19
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.3
mzht2vy9k5cfhujmb1
15 Mar 19
Matinas BioPharma Announces Proposed Public Offering of Common Stock
5:15pm
8-K
EX-1.1
mg18iqqea5g7 f7rhf7
15 Mar 19
Matinas BioPharma Announces Proposed Public Offering of Common Stock
5:15pm
424B5
wyi9mj9jwn52w3i6wfz7
14 Mar 19
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
lywk37n4 mrly
25 Feb 19
Prominent Cardiovascular Expert, James J. Ferguson, M.D., FACC, FAHA Joins Matinas BioPharma as Chief Medical Officer
8:15am
8-K
EX-10.1
vpgt9kcpo4s2uqw
3 Jan 19
Matinas BioPharma Appoints Keith A. Kucinski, CPA, MBA as Chief Financial Officer
8:05am
8-K
EX-10.1
fmhdr1
15 Oct 18
Departure of Directors or Certain Officers
8:00am
8-K
EX-10.1
14rtj2r
19 Jun 18
Matinas BioPharma Announces Pricing of $8.0 Million Public Offering
5:19pm